1. Research Funding
  2. Division of Discovery Science & Technology (Bioengineering)

Division of Discovery Science & Technology (Bioengineering)

This division supports the development and demonstration of modular platform technologies (without preference for any disease or application) that manipulate and interface with biology to enable new paradigms of clinical intervention for human health.

Core Program Areas: Biotransducers Cluster

Biochemical Engineering

Luisa Russell, Ph.D.

Bioelectromagnetic Engineering

Moria Fisher Bittmann, Ph.D.

Biomechanical Engineering

Moria Fisher Bittmann, Ph.D.

Biophotonic Engineering

David Rampulla, Ph.D.

Core Program Areas: Bioengineered Systems Cluster

Biomimetic Systems

Luisa Russell, Ph.D.

Rehabilitation Engineering

Michael Wolfson, Ph.D.

Mathematical Modeling

Grace C.Y. Peng, Ph.D.

Robotic Systems

Moria Fisher Bittmann, Ph.D.

illustration synthetic biology process

David Rampulla, Ph.D.

Core Program Areas: Translation and Commercialization Cluster

Resource Centers for Bioengineering Technologies

Ilana Goldberg, Ph.D.

Small Business

Ilana Goldberg, Ph.D.

Collaborations

An important aspect of the Institute’s mission is encouraging collaborations among the institutes and centers at NIH, other federal agencies, and the private sector.

  • Interagency Modeling and Analysis Group (IMAG) – IMAG brings together program officers across federal agencies to communicate, disseminate, and plan collaborative activities and joint initiatives related to computational and analytical modeling and analysis of biomedical, biological, and behavioral systems, see IMAG Research. IMAG also hosts the NIH Population Modeling Scientific Interest Group and the Multi-scale Modeling (MSM) Consortium.
     
  • Synthetic Biology Consortium (SBC) - The SBC is a trans-NIH effort to foster collaborations among researchers and share synthetic biology technologies to address unmet needs in biology and medicine.

Division Staff

Related News

  • Synthetic mucus can mimic the real thing

    Grantee News ·

    Researchers have generated synthetic mucins with a polymer backbone that more accurately mimics the structure and function of naturally occurring mucins. They also showed that these synthetic mucins could effectively neutralize the bacterial toxin that causes cholera.

  • A better treatment for sickle cell disease

    Grantee News ·

    Sickle cell disease is the most prevalent inherited blood disorder in the world, affecting 70,000 to 100,000 Americans. However, it is considered an orphan disease, meaning it impacts less than 200,000 people nationally, and is therefore underrepresented in therapeutic research.

  • My life-changing prosthetic hand

    Grantee News ·

    In Made of Stronger Stuff, psychologist Kimberley Wilson and doctor Xand van Tulleken learn how Jason became the first person in the world with a neural enabled prosthetic hand, and as a result, regained the sensation of touch in his fingers. Source: BBC Radio Podcast.

  • NIH to evaluate COVID-19 at-home testing system

    Press Releases ·

    diagnostic test in a box
    An NIH-funded research team has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which received FDA emergency use authorization for use with a prescription.

  • Ionic liquid uniformly delivers chemotherapy to tumors while destroying cancerous tissue

    Grantee News ·

    Vascular and interventional radiologists report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab. This discovery could solve a problem that has long plagued drug delivery to tumors.
View All News